Fluconazole as prophylaxis against fungal infection in patients with advanced HIV infection

Archives of Internal Medicine

Volumn 157, Issue 1, 1997, Pages 64-69

  Manfredi, Robcrto ^a   Mastroianni, Antonio ^a   Coronado, Olga V ^a   Chiodo, Francesco ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CD4 ANTIGEN; FLUCONAZOLE; NYSTATIN;

ADULT; AGED; ARTICLE; CANDIDIASIS; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CRYPTOCOCCOSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0031013874     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.1.64     Document Type: Article

References (27)

1. Powderly W. Cryptococcal meningitis and AIDS. Clin Infect Dis. 1993;17:837-842.
2. Gallant JE, Moore RD, Chaisson RE. Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med. 1994;120:932-944.
3. Reef SE, Mayer KH. Opportunistic candidal infections in patients infected with human immunodeficiency virus: prevention issues and priorities. Clin Infect Dis. 1995;21(suppl 1):S99-S102.
4. Pinner RW, Hajjeh RA, Powderly WG. Prospects for preventing cryptococcosis in persons infected with human immunodeficiency virus. Clin Infect Dis. 1995;21(suppl 1):S103-S107.
5. Powderly WG, Saag MA, Cloud GA, et al. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992;326: 793-798.
6. Clumeck N. Primary prophylaxis against opportunistic infections in patients with AIDS. N Engl J Med. 1995;332:739-740.
7. Perfect JR. Antifungal prophylaxis: to prevent or not. Am J Med, 1993;94:233-234.
8. Como JA, Dismukes WE. Oral azole drugs as systemic antifungal agents. N Engl J Med. 1994;330:263-272.
9. Wheat LJ, Goldman M. Antifungal prophylaxis in AIDS: should it be the standard of care? AIDS Clin Care. 1994;6:27-30.
10. Hay RJ. Cryptococcosis, AIDS, and clinical trials. Lancet. 1995;345;530-531.
11. Nightingale SD, Cal SX, Peterson DM, et al. Primary prophylaxis with fluconazole against systemic fungal infections in HIV-positive patients. AIDS. 1992; 6:191-194.
12. Quagliarello VJ, Viscoli C, Horwitz RI. Primary prevention of cryptococcal meningitis by fluconazole in HIV-infected patients. Lancet. 1995;345:548-552.
13. Newton JA Jr, Tasker SA, Bone WD, et al. Weekly fluconazole for the suppression of recurrent thrush in HIV-seropositive patients: impact on the incidence of disseminated cryptococcal infection. AIDS. 1995;9:1286-1287.
14. Powderly WG, Finkelstein DM, Feinberg J, et al, for the NIAID AIDS Clinical Trials Group. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. N Engl J Med. 1995;332:700-705.
15. Galgiani JN. Fluconazole, a new antifungal agent Ann Intern Med. 1990;113: 177-179.
16. Leen CLS, Dunbar EM, Ellis ME, Mandai BK. Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double blind placebo controlled study. J Infect 1990;21: 55-60.
17. Stevens DA, Greene SI, Lang OS. Thrush can be prevented in patients with acquired immunodeficiency syndrome-related complex: randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily. Arch Intern Med. 1991;151:2458-2464.
18. Marriott DJE, Jones PD, Hoy JF, Speed BR, Harkness JL. Fluconazole once a week as secondary prophylaxis against oropharingeal candidiasis in HIV-infected patients: a double-blind placebo-controlled study. Med J Aust 1993; 158:312-316.
19. Pradier C, Bernard E, Lubick C, et al. Does fluconazole prevent cryptococcal meningitis in human immunodeficiency virus-infected patients? J Infect Dis. 1992;165:787.
20. Cotton D, Weinberg D. Survey results: treatment decisions in HIV care. AIDS Clin Care. 1992;4:85-91.
21. Powderly WG. Resistant candidiasis. AIDS Res Hum Retroviruses. 1994;10: 925-929.
22. Parente F, Cernuschi M, Rizzardini G, Lazzarin A, Valsecchi L, Bianchi-Porro G. Opportunistic infections of the esophagus not responding to oral systemic antifungals in patients with AIDS: their frequency and treatment. Am J Gastroenterol. 1991;85:1729-1734.
23. Sanguineti A, Carmichael JK, Campbell K, Fluconazole-resistant Candida albicans after long-term suppressive therapy. Arch Intern Med. 1993;153:1122-1124.
24. Baily GG, Perry FM, Denning DW, Mandai BK. Fluconazole-resistant candidosis in an HIV cohort. AIDS. 1994;8:787-792.
25. Newman SL, Flanigan TP, Fisher A, Rinaldi MG, Stein M, Vigilante K. Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS. Clin Infect Dis. 1994;19:684-686.
26. Stellbrink HJ, Albrecht H, Fenske S, Koperski K. Candida krusei sepsis in HIV infection. AIDS. 1992;6:746-748.
27. Peetermans W, Bobbaers H, Verhaegen J, Vandepitte J. Fluconazole-resistant Cryptococcus neoformans var. gattii in an AIDS patient. Acta Clin Belg. 1993; 48:405-409.